台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    83.1
  • 漲跌
    ▲2.3
  • 漲幅
    +2.85%
  • 成交量
    221
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
訊聯 (1784)籌碼相關-凱基-新店 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-新店 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2000.00080.4081.3004400.00%
2025/01/09083.10083.5082.5004660.00%
2025/01/08083.8000.0083.5004650.00%
2025/01/03080.20080.2080.0004790.00%
2024/12/30080.40080.4079.5004910.00%
2024/12/27080.60080.6080.1004950.00%
2024/12/24081.40079.9080.0005270.00%
2024/12/18082.70082.3382.4005480.00%
2024/12/17083.20083.2083.4005820.00%
2024/12/16085.90090.0082.0005980.00%
2024/12/13090.75090.9087.2005870.00%
2024/12/12093.20093.2092.6005800.00%
2024/12/1000.00293.8093.80-2559-0.36%
2024/12/0900.00192.3092.30-1561-0.18%
2024/12/06099.20099.6095.0005600.00%
2024/12/03096.90196.1095.70-1521-0.19%
2024/11/27093.30093.4093.1005270.00%
2024/11/2600.00395.2095.20-3538-0.56%
2024/11/2500.000.198.0097.40-0.1565-0.02%
2024/11/22093.90193.6092.80-1577-0.17%
2024/11/21497.80193.8093.3035840.51%
2024/11/20096.10096.1095.9005650.00%
2024/11/14089.80089.5088.4006350.00%
2024/11/13089.20089.2089.5006430.00%
2024/11/0800.00793.8494.10-7711-0.98%
2024/11/04190.7000.0090.8017910.13%
2024/10/2800.000.195.5093.50-0.1879-0.01%
2024/10/24097.80096.6196.2009830.00%
2024/10/23499.85099.7099.8041,0120.40%
2024/10/090.196.8000.0096.100.11,5850.01%
2024/09/3010102.7500.00100.00101,7060.59%
2024/09/2600.00198.9098.50-11,964-0.05%
2024/09/24196.80097.0096.6012,2460.04%
2024/09/190106.0000.00102.5002,2880.00%
2024/09/120105.5000.00104.0002,3690.00%
2024/09/112102.0000.00102.0022,4250.08%
2024/09/0900.000103.00105.5002,4990.00%
2024/09/052110.5000.00105.5022,5660.08%
2024/09/0200.001117.00116.50-12,691-0.04%
2024/08/2600.000116.50120.5002,9860.00%
2024/08/200117.500122.50116.0002,9730.00%
2024/08/160113.0000.00113.0002,9330.00%
2024/08/121116.001115.00112.0002,9620.00%
2024/08/0900.001109.00107.50-12,926-0.03%
2024/08/081106.0000.00106.0012,9180.03%
2024/07/3100.002119.00114.50-22,790-0.07%
2024/07/303115.331119.00116.5022,7790.07%
2024/07/2900.001121.00113.50-12,748-0.04%
2024/07/223147.003136.50136.0002,6470.00%
2024/07/197154.935148.60145.5022,5720.08%
2024/07/182158.002161.25161.5002,3020.00%
2024/07/174147.382144.50147.0022,2110.09%
2024/07/1500.005144.00143.50-52,196-0.23%
2024/07/121139.001139.00139.0002,1770.00%
2024/07/091155.991153.00143.5002,1300.00%
2024/07/080137.002144.25146.00-22,083-0.10%
2024/07/0500.001133.00133.00-12,039-0.05%
2024/07/035137.401133.00133.0042,0080.20%
2024/07/025138.004.1133.06140.000.91,9350.05%
2024/07/013127.836133.42139.50-31,729-0.17%
2024/06/2815124.8010122.55127.0051,6230.31%
2024/06/2600.005103.56105.00-51,428-0.35%
2024/06/2500.00196.2095.60-11,388-0.07%
2024/06/24194.20195.5094.2001,3710.00%
2024/06/21894.8100.0093.7081,3510.59%
2024/06/2000.001197.8599.40-111,308-0.84%
2024/06/191295.90299.2094.20101,2790.78%
2024/06/183.197.19296.2096.101.11,2420.09%
2024/06/17191.50195.9091.5001,1950.00%
2024/06/13185.20486.9585.30-31,125-0.27%
2024/06/0700.00283.6583.00-21,017-0.20%
2024/06/06282.0500.0081.2029690.21%
2024/06/05180.30383.2087.00-2907-0.22%
2024/06/04683.57487.3880.0028360.24%
2024/06/03584.66186.5085.0047730.52%
2024/05/31281.90482.0582.40-2690-0.29%
2024/05/30678.22378.2077.3036070.49%
2024/05/29074.90275.6074.00-2547-0.37%
2024/05/22069.60070.5069.6004870.00%
2024/05/2000.00269.3071.70-2471-0.42%
2024/05/17169.30170.6069.9004540.00%
2024/05/1300.001566.0565.50-15415-3.61%
2024/05/07564.6000.0065.9054021.24%
2024/05/0200.00966.7066.50-9380-2.36%
2024/04/25362.9000.0069.4033090.97%
2024/04/22660.8000.0060.8062782.15%
2024/04/19160.0000.0058.8012810.35%
2024/04/12064.5000.0064.0002760.00%
2024/04/11065.2000.0064.5002750.00%
2024/04/01262.6000.0063.0022540.79%
2024/03/22864.5800.0064.2082563.12%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音